Vimarsana
Biggest News Aggregation in the World

Rob Meijer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Meijer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Meijer Today - Breaking & Trending Today

Dutch Supreme Court orders return of historical artifacts to Ukraine - National - Vimarsana News

Dutch Supreme Court orders return of historical artifacts to Ukraine - National

The collection of archaeological objects, some more than 2,000 years old, was on display in Amsterdam when Russia annexed the Crimean Peninsula from Ukraine in 2014.

Amphera and Alligator Bioscience reveal mitazalimab-MesoPher update - Vimarsana News

Amphera and Alligator Bioscience reveal mitazalimab-MesoPher update

Therapy is being used during pivotal phase 1 study into patients with pancreatic cancer - News - PharmaTimes

Bay Area Reporter :: Jack Fritscher's 'Profiles in Gay Courage' - Vimarsana News

Bay Area Reporter :: Jack Fritscher's 'Profiles in Gay Courage'

Jack Fritscher's newest book, "Profiles in Gay Courage: Leatherfolk, Arts, and Ideas, Essays and Interviews," is an illustrated collection of thirteen essays celebrating "authentic leatherfolk founders, icons, and superstars" in our recent history.

Source: ebar.com
Bay Area Reporter :: Jack Fritscher's 'Profiles in Gay Courage' - Vimarsana News

Bay Area Reporter :: Jack Fritscher's 'Profiles in Gay Courage'

Jack Fritscher’s newest book, "Profiles in Gay Courage: Leatherfolk, Arts, and Ideas, Essays and Interviews," is an illustrated collection of thirteen essays celebrating "authentic leatherfolk founders, icons, and superstars" in our recent history.

Source: ebar.com
Amphera's MesoPher Cell Therapy Demonstrates Favourable Safety and Promising Survival in a Phase II Clinical Trial in Resected Pancreatic Cancer - Vimarsana News

Amphera's MesoPher Cell Therapy Demonstrates Favourable Safety and Promising Survival in a Phase II Clinical Trial in Resected Pancreatic Cancer

Positive results from first cohort of 10 patients from REACtiVe study published in European Journal of Cancer Amphera B.V. announces positive REACtiVe Phase 2 study safety and efficacy data from the